After 4-year review, FDA shuts down attempt to regulate CBD as a supplement and asks Congress for help - AgencyIQ by POLITICO
FDA has concluded that CBD cannot be regulated as a dietary supplement and is asking Congress for a new regulatory pathway. This means CBD products currently marketed as supplements are in violation of FDA rules, and enforcement actions are likely.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers involved with CBD products should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate; no grace period given. Enforcement actions can begin at any time.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA officially determined that CBD does not meet the definition of a dietary supplement and will not allow its sale as such without new legislation. Existing CBD supplement products are now considered adulterated.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers involved with CBD products
What you must do
Immediately stop marketing CBD as a dietary supplement; remove any CBD products labeled as supplements from the market; consult legal counsel to assess compliance and potential reformulation or reclassification.
Deadline
Immediate; no grace period given. Enforcement actions can begin at any time.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire
- US FDA New Dietary Ingredient Notification Submissions in the Last 4 Years - CIRS Group
- FDA's 2016 New Dietary Ingredient Draft Guidance - Food and Drug Law Institute (FDLI)
- Texas Updates Food Labeling Law: 44 Ingredients Require Warning Labels - CIRS Group